Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy
PLOS One · 2025
DOI: 10.1371/journal.pone.0330763 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, 2025. Verfasst von Anna Puggina und 11 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Verona, Italy. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Health Knowledge, Attitudes, Practice, Physicians, Attitude of Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) causes substantial morbidity and mortality among older adults and individuals with chronic diseases, putting pressure on healthcare systems. RSV vaccines became available in 2023, however, physicians’ knowledge and attitudes regarding RSV and RSV vaccines may hinder uptake. We aimed to understand physicians’ knowledge, attitudes, and perceptions of respiratory infections, including RSV, and vaccination. A pre-tested cross-sectional survey was fielded with physicians who commonly administer or recommend respiratory vaccines in Germany and Italy. Regression models assessed physicians’ characteristics associated with knowledge and perceptions of RSV. Overall, 307 physicians (Germany: n = 152; Italy: n = 155) completed the survey. Physicians had good mean RSV disease knowledge scores (Germany: 3.8/5; Italy: 3.3/5). Most (Germany: 68%; Italy: 72%) indicated wanting further information on RSV, versus 96%; Italy: >92%) and ≥60 years with chronic conditions (Germany: >95%; Italy: >87%). Physicians seeing >100 versus ≤100 patients weekly, and general practitioners versus other specialists, perceived RSV burden as more important. Perceived barriers to RSV vaccination included lack of national recommendation and reimbursement (Germany: 92%; Italy: 89%), and patients not being informed on getting vaccinated (Germany: 71%; Italy: 59%). In conclusion, physicians generally considered RSV an important pathogen for older adults and those with chronic conditions at risk of severe infection. Most wanted more information on RSV, thus medical education is important to address knowledge gaps and enable physicians to guide patients in making informed vaccination decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GSK, Verona, Italy.
- GSK, Wavre, Belgium.
- Kielo Research, Zug, Switzerland.
- LAMSADE, CNRS, Université Paris-Dauphine, Université PSL, Paris, France.
- Hematology Onkology Germering, Germering, Germany and University of Munich, Munich, Germany.
- Dipartimento di Scienze della Salute, Università degli Studi di Firenze, Florence, Italy.
ORCID-Profile: Alen Marijam, Paolo Bonanni, Tommi Tervonen
Förderung
- GSK
Zitieren
APA
Puggina, A., Marijam, A., Cailloux, O., Vicentini, M., Turriani, E., Verelst, F., Last, T., Rieger, C., Bonanni, P., de Waure, C., Marijic, P., & Tervonen, T. (2025). Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy. PLOS One. https://doi.org/10.1371/journal.pone.0330763
Vancouver
Puggina A, Marijam A, Cailloux O, Vicentini M, Turriani E, Verelst F, et al. Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy. PLOS One. 2025. doi:10.1371/journal.pone.0330763
BibTeX
@article{Puggina2025,
author = {Puggina, Anna and Marijam, Alen and Cailloux, Olivier and Vicentini, Marta and Turriani, Elisa and Verelst, Frederik and Last, Theo and Rieger, Christina and Bonanni, Paolo and de Waure, Chiara and Marijic, Pavo and Tervonen, Tommi},
title = {Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330763}
}
EUVIMED